Investigation of Cytotoxic Activity in Four Stachys Species from Iran

authors:

avatar Mahnaz Khanavi a , avatar Azadeh Manayi a , avatar Mahnaz Lotfi b , avatar Rofeyde Abbasi b , avatar Maryam Majdzadeh a , avatar Seyed Nasser Ostad c , *

Department of Pharmacognosy, Faculty of Pharmacy and Traditional Iranian Madicines and Pharmacy Research Center
Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran.
Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.

how to cite: Khanavi M, Manayi A, Lotfi M, Abbasi R, Majdzadeh M, et al. Investigation of Cytotoxic Activity in Four Stachys Species from Iran. Iran J Pharm Res. 2012;11(2):e125869. https://doi.org/10.22037/ijpr.2012.1144.

Abstract

The aerial parts of Stachys laxa Boiss. and Buhse. from Siah-bishe in Mazandaran province, Stachys trinervis Aitch. and Hemsl. from Karaj in Alborz province, Stachys subaphylla Rech. F. and Stachys turcomanica Trautv. from Golestan province have been collected in May 2008. Total extracts were obtained through MeOH/H2O (80/20) and then partitioned between CHCl3, EtOAc and MeOH. These fractions and total extracts have been investigated for in-vitro cytotoxic activity against the colon carcinoma (HT-29), colorectal adenocarcinoma (Caco-2), breast ductal carcinoma (T47D) and Swiss mouse embryo fibroblast (NIH 3T3) cell lines using MTT assay (3-(4,5-di methyl thiazol-2-yl)-2,5-di phenyltetrazolium bromide). At each cell line, doses of 3.125, 6.25, 12.5, 25, 100, 200, 400 and 800 µg/mL in 1% (v/v) DMSO of all samples were tested. Ethyl acetate and chloroform fractions of Stachys laxa against proliferation of T47D and HT-29 cell lines and chloroform fraction of Stachys subaphylla and Stachys subaphylla ethyl acetate fraction toward T47D cell line exhibited highest cytotoxic activity (IC50 < 50 µg/mL). Ethyl acetate and chloroform fractions of Stachys turcomanica against HT-29 cell line, except methanol fraction of Stachys subaphylla, the other extrcts on T47D cell line, represented moderate cytotoxic activity (IC50 < 70 µg/mL). All fractions of S. trinervis demonstrated no effective cytotoxic activity. IC50 values confirmed that the growth and proliferation of HT-29 and T47D cells were most affected by chloroform and ethyl acetate fractions of Stachys laxa and Stachys turcomanica due to their nonpolar compounds.

Introduction

The genus Stachys belongs to the plant family of Lamiaceae. The most species of this genus has been previously analyzed in numerous studies concerning their chemical composition, pharmacological properties and therapeutic uses. This family is well represented in the flora of Iran, at least with 200-300 species in the world (1) and 34 species in Iran (2). Phytochemical investigation of some Stachys species has demonstrated phenolic acids, tannins (3, 4), flavonoids (5) and phenyl ethanoid glycosides (6, 7). There are some reports about pharmacological activities of this genus including anticancer (8, 9), antibacterial (10- 13), antioxidant effects (14- 16), anti-inflammatory (17-22), anti-nephritic (23) and anti-anxiety (24). Some Stachys species are used in folk medicine for healing wounds, disinfectant, treating abdominal pains, asthma, rheumatic and inflammatory disorders, anti-spasmodic and anti-fever (20, 25). Essential oils of Stachys cretica ssp. lesbiaca Rech. fil. and S. cretica ssp. trapezuntica Rech. fil. inhibit the growth of HL-60 and Ishikawa human tumor cell lines; the main component in both of them was germacrene D (26). There was an investigation about the essential oil of S. turcomanica; the major constituents were identified as germacrene D (17.4 %), 7-epi-á-selinene (10.5 %), β-elemene (9.2 %) and β-pinene (8.6 %) (27). Major components of S. trinervis oil were identified as α-pinene (42.68 %), δ-2-carene (31.90 %), 1,8-cineole (7.03 %), limonene (4.39 %) and (Z)-β-ocimene (4.21 %). S. subaphylla oil major constituents were δ-2-carene (23.93 %), α-pinene (19.29 %), sabinene (19.11 %), δ-3-carene (9.22 %) and (Z)-β- ocimene (5.90 %) (28). Thirty three constituents from essential oil of S. laxa have been identified and the major constituents were germacrene D (40.1%), β-caryophylene (16.7%), β-phellandrene (5.5%), caryophyllene oxide (4.6%), linalool (3.2%) and α-cadinol (2.6%) (29). The cytotoxicity of some Stachys species against A431, HeLa and MCF-7 were examined. S. recta and S. palustris stem extract inhibit the growth of HeLa cells. An S. rectum was significantly active toward the breast MCF7 cell line (30). More than half of drugs in cancer therapy were obtained from natural products or related to them (31). Hence in this study, cytotoxic activity of S. laxa Boiss. and Buhse., S. turcomanica Trautv, S. subaphylla Rech. F., S. trinervis Aitch. and Hemsl. have been investigated toward four cell lines by MTT assay.

Experimental

Plant material

The aerial parts of S. laxa Boiss. and Buhse., from Siah-bishe in Mazandaran province, S. trinervis Aitch. and Hemsl from Karaj in Alborz province, and S. subaphylla Rech. F. and S. turcomanica Trautv. from Golestan province were collected in May 2008. The plants have been identified and deposited at the Herbarium of Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Extraction

Freshly collected aerial parts of four species of Stachys were cleaned and shade dried. These parts were coarse powdered in a hand mill and stored at room temperature. Two hundred grams of powdered plants were extracted through perculation method with 80% aq. MeOH three times at room temperature. The extract was evaporated using rotary evaporator and consequently partitioned between CHCl3, EtOAc and MeOH. Each fraction evaporated with rotary evaporator and has been stored at refrigerator for the investigation of cytotoxic activity.

Table 1

Cytotoxic activity of total extract and fractions of four species of Stachys

SampleCell Linesa (MTT assay)
HT-29Caco-2T47DNIH/ 3T3
Stachys laxa
Total extract421.97 ± 8.71> 1000239.78 ± 16.92508.77 ± 45.56
Methanol fr.265.83 ± 46.52> 1000254.1 ± 7.45405.7 ± 74.18
Ethyl acetate fr.134.004 ± 1.764116.53 ± 18.2318.079 ± 2.24831.452 ± 1.554
Chloroform fr.27.007 ± 2.096101.65 ± 12.421.106 ± 2.49141.294 ± 8.391
Stachys subaphylla
Total extract> 1000> 100060.15 ± 3.72771.26 ± 164.67
Methanol fr.> 1000> 1000771.26 ± 197.38> 1000
Ethyl acetate fr.-116.52 ± 2.7851.05 ± 8.89-
Chloroform fr.234.86 ± 11.28183.85 ± 8.8743.411 ± 9.9974.27 ± 2.34
Stachys trinervis
Total extract> 1000> 1000358.1 ± 14.14> 1000
Methanol fr.> 1000> 1000630.96 ± 29.99649.23 ± 17.91
Ethyl acetate fr.241.66 ± 14.71338.22 ± 1.02128.35 ± 6.65110.05 ± 5.56
Chloroform fr.> 1000> 1000383 ± 4.01674.84 ± 67.37
Stachys turcomanica
Total extract219.58 ± 14.21> 1000103.67 ± 12.43308.7 ± 1.34
Methanol fr.693.57 ± 56.91> 1000708.60 ± 25.8802.58 ± 26.84
Ethyl acetate fr.66.10 ± 5.4387.08 ± 8.930.14 ± 1.7850.45 ± 3.45
Chloroform fr.66.84 ± 7.92187.89 ± 11.7251.38 ± 9.4958.22 ± 4.06
Methotrexate0.23 ± 0.020.32 ± 0.040.16 ± 0.090.24 ± 0.013

Cytotoxicity assay

The colon carcinoma (HT-29), colorectal adenocarcinoma (Caco-2) and ductal carcinoma (T47D) cell lines were mentioned as exponentially growing cultures in RPMI 1640 cell culture medium (PAA, Germany), supplemented with 10% fetal bovine serum (FBS: Gibco, USA), for HT-29 cells and 15% FBS for Caco-2 and T47D cells. The Swiss mouse embryo fibroblast (NIH 3T3) cell line was kept in Dulbecco’s modified Eagle’s medium (DMEM; PAA, Germany) supplemented with 10% FBS. 100 IU/mL penicillin and 100 µg/mL streptomycin (Roche, Germany) were added to the media. All the cell lines were cultured at 37°C in air /carbon dioxide (95:5) atmosphere.

Cytotoxic activity was measured using modified MTT assay (31). 1×104 cells/well were plated in 96-well plates (Nunc, Denmark) and incubated for 24 h before the addition of drugs. After 96 h of incubation in Caco2 cells and 48 h of incubation in HT-29, NIH/3T3 and T47D cells, 20 µL of MTT (Merck, Germany) reagent (5 mg/mL) in phosphate buffered saline (PBS) was added to each well. The plates were incubated at 37°C for 4 h. The medium was discharged and the formazan blue, which had been formed in the cells, were dissolved with 100 µL dimethyl sulphoxide (DMSO). After the incubation at 37°C for 10 min, absorbance at 570 nm at the dissolved solutions was detected using a micro plate reader (Anthos, Austria). The cell viability in MTT assay was calculated as the percentage of control value. Methotrexate was used as the positive control. Cytotoxicity was expressed as the concentration of extract inhibiting cell growth with 50% (IC50 ± SD). All tests and analysis were run in triplicate.

Statistical analysis

IC50 (the median growth inhibitory concentration) values were calculated from the IC50 of dose-response curve in the sigma plot 11 software. Data representative of three independent experiments with similar results were presented as mean ± SD.

Results

The effects of these plant extracts on the proliferative response of the HT-29, Caco-2 and T47D cell lines have been analyzed by treating the cells with different concentrations of the extracts and significant decrease in cell lines proliferation were observed. IC50 ± SD are reported in Table 1. The chloroform and ethyl acetate fractions of S. laxa Boiss. showed high cytotoxicity on T47D, HT-29 (IC50 < 50 µg/mL). The cytotoxicity of ethyl acetate fraction of S. turcomanica Trautv. and chloroform fraction of S. subaphylla were better than the other fractions on T47D cell line (IC50 < 50 µg/mL). Total extract and fractions of S. trinervis did not affect the cell lines.

Discussion

Among all the samples, nonpolar (chloroform and ethyl acetate fractions) fractions of S. laxa exhibited greatest cytotoxicities on T47D and HT-29 cell lines compared with polar fraction and total extract. According to the data, the cytotoxic activity of chloroform and ethyl acetate fractions on HT-29 and T47D cell lines were much stronger than that of Caco-2. It indicated that chloroform and ethyl acetate fractions of S. laxa had potential cytotoxic selectivity on T47D cell line. There was a report about the antioxidation and total phenol content of some Stachys spp. The research implied that total phenol content and FRAP value of methanolic extract are in this order: S. laxa > S. turcomanica > S. subaphylla > S. trinervis (33). Except S. subaphylla total extract against T47D cell line, the other methanolic extracts have indicated the same order of cytotoxic activity on T47D and HT-29. Higher cytotoxic activity of nonpolar fraction of S. laxa and S.turcomanica may be due to the high content of germacrene D in their essential oil, same as the Stachys cretica ssp. (34, 35), but main components of S. subaphylla and S. trinervis essential oils were identified as monoterpene hydrocarbons. In comparison with another fraction, methanolic and total fractions of all samples demonstrated slightly cytotoxic effect on cell line tested. The real IC50 values of fractions of four species Stachys may be considerably lower than the positive control (Methotrexate) since its pharmacological active compounds are not pure and further researches are needed for defining potential component as cytotoxic natural medicines.

References

  • 1.

    Rechinger KH, Hedge IC. Flora Iranica. Akademisch Druck-und Verlagsanstalt, Graz, Austria. 1982;150:360-361.

  • 2.

    Mozaffarian V. a Dictionary of Iranian Plant Names. Tehran: Farhang Moaser; 1996. 522 p.

  • 3.

    Vundac VB, Brantner AH, Plazibat M. Content of phenolic constituents and antioxidant activity of some Stachys taxa. Food Chem. 2007;104:1277-81.

  • 4.

    Vundac VB, Males Z, Plazibat M, Golja P, Cetina-Cizmek BC. HPTLC determination of flavonoids and phenolic acids in some Croatian Stachys taxa. J. Planar Chromatogr. Mod. TLC. 2005;18:269-73.

  • 5.

    El-Ansari MA, Nawwar MA, Saleh NAM. Stachysetin, a diapigenine-7-glucoside-p-p-dihydroxy-truxinate from Stachys aegyptiaca. Phytochem. 1995;40:1543-48.

  • 6.

    Miyase T, Yamamoto R, Ueno A. Phenyl ethanoid glycosides from Stachys officinalis. Phytochem. 1996;43:475-79.

  • 7.

    Nishimura H, Sasaki H, Inagaki N, Chin M, Mitsuhashi H. Nine phenethyl alcohol glycosides from Stachys seiboldii. Phytochem. 1991;30:659-69.

  • 8.

    Amirghofran Z, Bahmani M, Azadmehr A, Javidnia K. Anticancer effects of various Iranian native medicinal plants on human tumor cell lines. Neoplasma. 2006;53:428-33. [PubMed ID: 17013538].

  • 9.

    Amirghofran Z, Bahmani M, Azadmehr A, Javidnia K. Immunomodulatory and apoptotic effects of Stachys obtusicrena on proliferative lymphocytes. Med. Sci. Monit. 2007;13:145-50.

  • 10.

    Stamatis G, Kyriazopoulos P, Golegou S, Basayiannis A, Skaltsas S, Skaltsa H. In-vitro anti-Helicobacter pylori activity of Greekherbal medicines. J. Ethnopharmacol. 2003;88:175-9. [PubMed ID: 12963139].

  • 11.

    Grujic-Jovanovic S, Skaltsa HD, Marin P, Sokovic M. Composition and antibacterial activity of the essential oil of six Stachys species from Serbia. Flav. Fragr. J. 2004;19:139-44.

  • 12.

    Sonboli A, Salehi P, Nejad EbrahimiS. Essential oil composition and antibacterial activity of the leaves of Stachys schtschegleevii from Iran. Chem. Nat. Compd. 2005;41:171-4.

  • 13.

    Digrak M, Hakki AlmaM, Ilcim A. Antibacterial and antifungal activities of Turkish medicinal plants. Pharm. Biol. 2001;39:346-50.

  • 14.

    Aydin A, Sener B, Cakici I, Turan NN, Erdemoglu N. Antioxidant activities of some Lamiaceae plant extracts. Phytother. Res. 2006;20:91-3. [PubMed ID: 16444659].

  • 15.

    Kukik J, Petrovic S, Niketic M. Antioxidant activity of four endemic Stachys taxa. Biol. Pharm. Bull. 2006;29:725-9. [PubMed ID: 16595907].

  • 16.

    Matkowski A, Piotrowska M. Antioxidant and free radical scavenging activities of some medicinal plants from the Lamiaceae. Fitoterapia. 2006;77:346-53. [PubMed ID: 16713687].

  • 17.

    Khanavi M, Sharifzadeh M, Hadjiakhoondi A, Shafiee A. Phytochemical investigation and anti-inflammatory activity of aerial parts of Stachys byzanthina C. Koch.J. Ethnopharmacol. 2005;97:463-8.

  • 18.

    Khanavi M, Sharifzadeh M, HadjiakhoondiA, Shafiee A. Anti-inflammatory activity of aerial part of Stachys byzanthina C. Koch. Iranian J. Pharm. Res. 2004;Supp. 2:55-56.

  • 19.

    Kukic J, Dobric S, Petrovic S. Influence of some Stachys taxa on carrageenan-induced paw edema in rats. Pharm. Biol. 2007;45:560-3.

  • 20.

    Maleki N, Garjani A, Nazemiyah H, Nilouroushan N, Eftekhar SadatAT, Allameh Z, Hasannia N. potent anti-inflammatory activities of hydroalcoholic extract from aerial parts of Stachys inflata on rats. J. Ethnopharmacol. 2001;75:213-8. [PubMed ID: 11297854].

  • 21.

    Sharifzadeh M, Sharifzadeh K, Khanavi M, Hadjiakhoondi A, Shafiee A. Anti-inflammatory activity of aerial parts of Stachys setifera and Stachys persica. Int. J. Pharmacol. 2005;1:132-7.

  • 22.

    Skaltsa HD, Bermejo P, Lazari DM, Silvan AM, Skaltsounis AL, Sanz A, Abad MJ. Inhibition of prostaglandin E2 and leukotriene C4 in mouse peritoneal macrophages and thromboxan B2 production in human platelets by flavonoids from Stachys chrysantha and Stachys candida. Biol. Pharm. Bull. 2000;23:47-53. [PubMed ID: 10706410].

  • 23.

    Hayashi K, Nagamatsu T, Ito M, Hattori T, Suzuki Y. Acotoside, a component of Stachys sieboldii MIQ, may be a promising antinephritic agent. Effects of acetoside on crescentic-type anti-GBM nephritis in rats. Jpn. J. Pharmacol. 1994;65:143-51. [PubMed ID: 7526020].

  • 24.

    Rabbani M, Sajjadi SE, Zarei HR. Anxiolytic effects of Stachys lavandulifolia Vahl on the elevated plus-maze model of anxiety in mice. J. Ethnopharmacol. 2003;89:271-6. [PubMed ID: 14611891].

  • 25.

    Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 2nd ed. New Jersey: Medical Economics Company; 2000. 832 p.

  • 26.

    Şerbetçi T, Demirci B, Güzelc ÇB, Kültür Ş, Ergüven M, Başer KHC. Essential oil composition, antimicrobial and cytotoxic activities of two endemic Stachys cretica subspecies (Lamiaceae) from Turkey. Nat. Prod. Commun. 2010;5:1369-74. [PubMed ID: 20922993].

  • 27.

    Firouznia A, Rustaiyan A, Masoudi S, Rahimizade M, Bigdeli M, Tabatabaei-Anaraki M. Volatile constituents of Salvia limbata, Stachys turcomanica, Scutellaria litwinowii and Hymenocrater elegans four Lamiaceae herbs from Iran. J. Essent. Oil-Bearing Plants. 2009;12:482-9.

  • 28.

    Khanavi M, Farahanikia B, Janbakhsh S, Sheibani S, Hoseini-Sajedi SM, Salahi-Oliaee MH, Ajani Y, Hadjiakhoondi A. Comparison of the essential oil composition of Stachys trinervis Aitch. & Hemsl. and Stachys subaphylla. F. J. Essent. Oil-Bearing Plants;11:406-12.

  • 29.

    Sajjadi SE, Mehregan I. Composition of the essential oil of Stachys laxa Boiss. & Buhse. Iranian J. Pharm. Res. 2003;8:57-58.

  • 30.

    Háznagy-Radnai E, Réthy B, Czigle Sz, Zupkó I, Wéber E, Martinek T, Falkay Gy, Máthé I. Cytotoxic activities of Stachys species. Fitoterapia. 2008;79:595-7. [PubMed ID: 18672034].

  • 31.

    Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007;70:461-77. [PubMed ID: 17309302].

  • 32.

    Rahman A, Choudhary MI, Thomsen WJ. Bioassay Techniques for Drug Development. Netherlands: Taylor and Francis Group; 2001. p. 34-35.

  • 33.

    Khanavi M, Hajimahmoodi M, Cheraghi-Niroomand M, Kargar Z, Ajani Y, Hadjiakhoondi A, Oveisi MR. Comparison of the antioxidant activity and total phenolic contents in some Stachys species. Afr. J. Biotechnol. 2009;8:1143-7.

  • 34.

    Kuźma Ł, Kalemba D, Różalski M, Różalska B, Więckowska-Szakiel M, Krajewska U, Wysokińska H. Chemical composition and biological activities of essential oil from Salvia sclarea plants regenerated in-vitro. Molecules. 2009;14:1438-47. [PubMed ID: 19384275].

  • 35.

    Richmond JD, Agius BR, Wright BS, Haber WA, Moriarity DM, Setzer WN. Essential oil compositions and cytotoxic activities of Dendropanax capillaris, Oreopanax nubigenus, and Schefflera rodrigueziana from Monteverde, Costa Rica. Nat. Prod. Commun. 2007;4:271-4. [PubMed ID: 19370937].